glp 1 after breast cancer GLP-1 Receptor Agonists in Cancer: A New Frontier in Obesity and Prognosis Management GLP-1s for Patients With Breast

This preparation phase is crucial for setting realistic expectations and building a solid foundation for your journey

GLP-1 (glucagon-like peptide-1) receptor agonists promote the production of insulin by the pancreas to regulate blood sugar levels and reduce appetite

GLP-1 microdosing means using a much smaller amount of medication than the standard dose to create gentle, targeted effects without the full intensity (and often, the full side effect profile) of higher doses

Maintain adequate hydration and nutrition, monitor blood glucose levels if advised, prioritise sleep, and manage any gastrointestinal symptoms

SNP, single nucleotide polymorphism